Evidence map›Paper›PMID 18852296›Full record

ArticleThe Journal of cell biology2008

The HECT E3 ligase Smurf2 is required for Mad2-dependent spindle assembly checkpoint.

Evan C Osmundson, Dipankar Ray, Finola E Moore, Qingshen Gao, Gerald H Thomsen, Hiroaki Kiyokawa

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Downregulation of Smurf2 ubiquitin ligase in pancreatic cancer cells reversed TGF-β-induced tumor formation.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Evan C OsmundsonDepartment of Molecular Pharmacology and Biological Chemistry, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Dipankar Ray
Finola E Moore
Qingshen Gao
Gerald H Thomsen
Hiroaki Kiyokawa
University of Illinois Urbana-Champaign · USNorthwestern University · USStony Brook University · US

Funding

Role of Cdc25A in breast cancerR01CA112282 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KIYOKAWA, HIROAKI · 2005 to 2015
$2.7M
CELL CYCLE GENES IN OVARIAN FUNCTION AND ONCOGENESISR01HD038085 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KIYOKAWA, HIROAKI · 2000 to 2008
$2.1M
Characterization of a novel BRCA2 binding protein, B2BP1R01CA095221 · NCI · NORTHSHORE UNIV HEALTHSYSTEM RES INST · PI GAO, QINGSHEN · 2003 to 2007
$1.3M
Functional Study of DSS1, a BRCA2 binding ProteinR01CA096986 · NCI · NORTHSHORE UNIV HEALTHSYSTEM RES INST · PI GAO, QINGSHEN · 2004 to 2008
$1.3M
Role of G1-Cdks in immortalization and oncogenesisR01CA100204 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KIYOKAWA, HIROAKI · 2003 to 2006
$1.2M
NCI NIH HHS CA095221NCI NIH HHS CA100204NCI NIH HHS CA112282NCI NIH HHS CA96986NCI NIH HHS R01 CA095221NCI NIH HHS R01 CA096986NCI NIH HHS R01 CA100204NCI NIH HHS R01 CA112282NICHD NIH HHS HD38085NICHD NIH HHS R01 HD038085
6 · The paper itself

Abstract

Activation of the anaphase-promoting complex/cyclosome (APC/C) by Cdc20 is critical for the metaphase-anaphase transition. APC/C-Cdc20 is required for polyubiquitination and degradation of securin and cyclin B at anaphase onset. The spindle assembly checkpoint delays APC/C-Cdc20 activation until all kinetochores attach to mitotic spindles. In this study, we demonstrate that a HECT (homologous to the E6-AP carboxyl terminus) ubiquitin ligase, Smurf2, is required for the spindle checkpoint. Smurf2 localizes to the centrosome, mitotic midbody, and centromeres. Smurf2 depletion or the expression of a catalytically inactive Smurf2 results in misaligned and lagging chromosomes, premature anaphase onset, and defective cytokinesis. Smurf2 inactivation prevents nocodazole-treated cells from accumulating cyclin B and securin and prometaphase arrest. The silencing of Cdc20 in Smurf2-depleted cells restores mitotic accumulation of cyclin B and securin. Smurf2 depletion results in enhanced polyubiquitination and degradation of Mad2, a critical checkpoint effector. Mad2 is mislocalized in Smurf2-depleted cells, suggesting that Smurf2 regulates the localization and stability of Mad2. These data indicate that Smurf2 is a novel mitotic regulator.

Indexed as

AnaphaseCalcium-Binding ProteinsCatalysisCell Cycle ProteinsCell LineCentrosomeChromosome PositioningChromosome SegregationCytokinesisEnzyme ActivationGene SilencingHumansMad2 ProteinsMetaphaseModels, BiologicalProtein TransportCalcium-Binding ProteinsCell Cycle ProteinsMAD2L1 protein, humanMad2 ProteinsRepressor ProteinsSMURF2 protein, humanUbiquitin-Protein Ligases

Identifiers

PMID18852296
PMCPMC2568023
OpenAlexW2123288293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.